| Open |
S2506 |
Testing mosunetuzumab alone, with zanubrutinib, and with polatuzumab vedotin for treating marginal zone lymphoma that came back or didn’t get better with treatment |
8/18/2026 |
|
0% |
|
|
| Open |
S2505 |
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation |
7/6/2026 |
|
0% |
|
|
| Closed |
S1105 |
Text Messaging Study |
3/27/2012 |
9/15/2013 |
100% |
|
|
| Closed |
S0508 |
Thalidomide + Temozolomide in Metastatic Melanoma |
6/1/2005 |
1/1/2007 |
100% |
|
Published
|
| Closed |
SWOG-8526 |
The Clinical Antitumor Activity of Recombinant Beta Interferon in Diffuse Mesothelioma |
8/1/1986 |
7/15/1988 |
|
|
Published
|
| Closed |
SWOG-8244 |
The Clinical Antitumor Activity of Vinblastine Sulfate in Diffuse Mesothelioma |
2/18/1983 |
3/20/1986 |
|
|
Published
|
| Closed |
SWOG-8027 |
The Natural History of Pathological Stage T1-2 N 0 M0 ER + Breast Cancer |
10/13/1980 |
9/10/1982 |
|
|
|
| Closed |
SWOG-7984 |
The Treatment of Chronic Stage CML with Pulse, Intermittent Busulfan Therapy with or without Oral Vitamin A |
7/10/1980 |
4/1/1987 |
|
|
Published
|
| Closed |
SWOG-8375 |
The Treatment of Favorable Histology Non-Hodgkin's Lymphoma with High Dose Pulse Chlorambucil and Recumbinant DNA Alpha-2 Interferon TEMPORARILY CLOSED: 7/26/85 |
2/1/1984 |
3/20/1986 |
|
|
|
| Closed |
SWOG-8049 |
The Treatment of Resected, Poor Prognosis Malignant Melanoma: Stage I: Surgical Excision Versus Surgical Excision + Vitamin A |
7/29/1981 |
3/15/1987 |
|
|
Published
|
| Closed |
SWOG-8111 |
The Treatment of Resected, Poor Prognosis Malignant: Stage II: Surgical Excision vs. Surgical Excision + Vitamin A vs. Surgical Exicision + Actinomycin-D and DTIC |
2/18/1983 |
3/16/1984 |
|
|
|
| Closed |
SWOG-8692 (INT-0075) |
Therapy In Premenopausal Women with Advanced, ER Positive or PgR Positive Breast Cancer: Surgical Oophorectomy vs. the LH-RH Analog, Zoladex |
8/1/1987 |
7/15/1995 |
77% |
|
Published
|
| Closed |
SWOG-8569 |
Therapy of Metastatic Malignant Melanoma with Recombinant Human Interleukin-2. |
8/1/1986 |
10/1/1988 |
|
|
Published
|
| Closed |
S1701 |
Thymic |
8/9/2018 |
9/29/2022 |
32% |
|
|
| Closed |
S0004 |
Tirapazamine/Cis/Etopo/RT in Limited SCLC |
10/15/2000 |
4/1/2002 |
60% |
|
Published
|
| Closed |
SWOG-9237 |
Topotecan in Resistant and Relapsing MM |
3/1/1993 |
2/15/1995 |
100% |
|
Published
|
| Closed |
S0222 |
TPZ/Cis/VP-16 and RT in Limited SCLC |
9/1/2003 |
7/24/2006 |
63% |
|
Published
|
| Closed |
SWOG-8012 |
Treatment for Advanced Adenocarcinoma and Large Cell Carcinoma of the Lung: FOMi vs CAP vs FOMi/CAP |
8/4/1980 |
12/23/1982 |
|
|
Published
|
| Open |
S1900N |
Treatment for Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations after Targeted Treatment and Chemotherapy (Lung-MAP Sub-study) |
8/3/2026 |
|
0% |
|
|
| Closed |
SWOG-8261 |
Treatment for Metastatic Non-Small Cell Lung Cancer(Squamous, Adenocarcinoma, and Large Cell Undifferentiated Histologies) with MiPE |
2/22/1982 |
1/31/1983 |
|
|
Published
|
